Skip to main content
. 2016 May 2;6:107. doi: 10.3389/fonc.2016.00107

Table 5.

Univariate analysis of timing of BRAF inhibitor on local control for metastases treated with GK SRS.

Timing of BRAF inhibitor use N # events Local control at 1 year (%) Median months to failure Relative risk of failure (95% CI) p-value
After GK SRS 11 4 64 7.7 1.0 0.71
Before and after GK SRS 16 2 87 1.6 2.0 (0.2–17.8)
Before GK SRS 2 1 50 2.7 0.7 (0.1–4.0)